MarcIDiamondMD
Neurology • Saint Louis, MODirector, Center for Alzheimer’s and Neurodegenerative Diseases Professor of Neurology, and Neuroscience University of Texas Southwestern Medical Center
Dr. Diamond is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Saint Louis, MO 63110Phone+1 314-362-1408Fax+1 314-747-2444
Education & Training
University of California (San Francisco)Residency, Neurology, 1994 - 1997- University of California (San Francisco)Internship, Internal Medicine, 1993 - 1994
- University of California San Francisco School of MedicineClass of 1993
Princeton UniversityAB, History, 1983 - 1987
Certifications & Licensure
CA State Medical License 1995 - 2020
TX State Medical License 2015 - 2019
MO State Medical License 2009 - 2015
Publications & Presentations
PubMed
- A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies.Anthony Aggidis, George Devitt, Yongrui Zhang, Shreyasi Chatterjee, David Townsend
Alzheimer's & Dementia. 2024-11-01 - Essential tremor with tau pathology features seeds indistinguishable in conformation from Alzheimer's disease and primary age-related tauopathy.Nil Saez-Calveras, Jaime Vaquer-Alicea, Charles L White 3rd, Yogesh Tak, Stephanie Cosentino
Biorxiv. 2024-10-20 - Cryo-EM structure of Alzheimer's disease tau filaments with PET ligand MK-6240.Peter Kunach, Jaime Vaquer-Alicea, Matthew S Smith, Jim Monistrol, Robert Hopewell
Nature Communications. 2024-10-01
Journal Articles
- Parkinson’s Disease and Multiple System Atrophy Have Distinct Α-synuclein Seed CharacteristicsBrandon B. Holmes, Tritia R. Yamasaki, Marc I. Diamond, Nigel J. Cairns, Paul T. Kotzbauer, The Journal of Biological Chemistry
Press Mentions
Why Do People Respond to Stress and Trauma so Differently? The Emerging Field of Neuroresilience May Have AnswersAugust 8th, 2024
A Rare Variant of APOE Delays Alzheimer's Disease Onset by Decades Now the Field Is Focused on Learning HowDecember 5th, 2019
After ‘Big Bang’ Discovery, UTSW Center for Alzheimer’s Gets $700K Boost from Aging Mind FoundationSeptember 24th, 2018- Join now to see all
Grant Support
- Cell-Cell Transfer And Propagation Of TAU AggregatesNational Institute Of Neurological Disorders And Stroke2010–2012
- Developing A Mouse Retinal Model Of Neurodegenerative DiseaseNational Institute Of Neurological Disorders And Stroke2011
- Efficacy And Mechanism Of Novel Androgen Receptor InhibitorsNational Cancer Institute2010
- Regulation Of Polyglutamine Aggregation And ToxicityNational Institute Of Neurological Disorders And Stroke2009
- Efficacy And Mechanism Of Novel Androgen Receptor InhibitorsNational Cancer Institute2008–2009
- Regulation Of Polyglutamine Aggregation And ToxicityNational Institute Of Neurological Disorders And Stroke2006–2009
- Cell And Molecular Screens Of Polyglutamine ToxicityNational Institute Of Neurological Disorders And Stroke2003–2004
- Polyglutamine-Induced Neurodegeneration In SBMANational Institute Of Neurological Disorders And Stroke1997–2001
External Links
- Lab Websitehttp://www.utsouthwestern.edu/labs/diamond/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
